Lifecore Biomedical, Inc.

NasdaqGS:LFCR

Author

Liger Cub
September 26, 2024

Hello. During the last conference call, an unidentified analyst asked LFCR’s management whether double-digit growth is a reasonable expectation beyond FY25. The question went unanswered. The truth is that such growth is achievable even with just the existing late-phase development pipeline and conservative time to commercialization assumptions. A better question would have been how much growth could accelerate if any of the catalysts outlined in this write-up were to materialize. Let’s dive in!

Thanks for reading, and I hope you find this valuable.

PREVIEW
FIRST PAGE

DOWNLOAD
FULL REPORT

Upgrade to Premium to download the full report and unlock other premium content.

ADDITIONAL RESOURCES
INVESTMENT WRITE-UPS

  • Laughing Water Write-Up: Link

  • Quick Pitch by Special Situation Investments (SSI): Link

  • VIC Write-Up and Messages: Link

  • Anonymous X Thread: Link

  • Laughing Water 1Q23 Investor Letter: Link

  • Laughing Water 2Q23 Investor Letter: Link

  • Laughing Water 3Q23 Investor Letter: Link

  • Laughing Water 4Q23 Investor Letter: Link

  • Laughing Water 1Q24 Investor Letter: Link

  • Laughing Water 2Q24 Investor Letter: Link

  • Greenhaven Road 1Q23 Investor Letter: Link

  • Greenhaven Road 2Q23 Investor Letter: Link

  • White Falcon 1Q24 Investor Letter: Link

  • Arquitos Capital 4Q23 Investor Letter: Link

If you have any questions or feedback, don't hesitate to reach out via email at [email protected].

Until next time,
The Tiger’s Prey

ABOUT
FOUR-PAGE INVESTMENT WRITE-UPS

Published on the second Thursday of each month, BMO.

"[You] should be able to tell me, in two minutes, four things: (1) the idea; (2) the consensus view; (3) [your] variant perception; and (4) a trigger event. No mean feat. In those instances where there was no variant perception-that is, solid growth recommendations within consensus-I generally had no interest and would discourage investing."

Michael Steinhardt, December 27, 2004, No Bull: My Life In and Out of Markets

The four-page investment write-ups are structured in the familiar format of sell-side equity research reports. Do not expect lengthy wiki-style documents. The focus will always be on delivering concise, differentiated views that active institutional and sophisticated retail investors can digest quickly before initiating their own research process. All write-ups are accompanied by institutional-grade models, which dissect the underlying thesis assumptions. Each spreadsheet is manually built from scratch as a typical comprehensive buy-side financial model.